PC3301 - Integrated Therapeutics 2

Cardiovascular, renal, endocrine and gastrointestinal disease are major causes of morbidity and mortality in the Australian population. Multiple factors contribute to a person's overall cardiovascular risk including nutrition, metabolism and other medical conditions such as hypertension, dyslipidaemia, renal disease and diabetes. Lifestyle factors such as physical inactivity, obesity, alcohol and smoking also play a role. Diabetes is a particularly important disease amongst this group, as it is an independent risk factor for CV disease, can lead to the failure of multiple organ systems, and is on the increase in Australia, particularly amongst Indigenous Australians and Torres Strait Islanders. This subject also introduces common conditions that affect the gastrointestinal and hepatobiliary systems and the principles of nutrition in adults and children. Students will begin to apply the pharmaceutical care planning process to address simple and moderately complex integrated patient presentations to develop foundational competence in the management of patients with multiple co-morbidities relating to these systems.

Learning Outcomes

• Describe the pathophysiology and clinical presentation of common cardiovascular, metabolic, renal, gastrointestinal and hepatobiliary diseases relevant to pharmacy practice;
• Effectively apply relevant clinical guidelines to the management of patients with cardiovascular, renal, endocrine (diabetes) and gastrointestinal disease;
• Develop, propose and evaluate pharmacological treatment plans for patients with common cardiovascular, metabolic, renal, gastrointestinal and hepatobiliary diseases;
• Demonstrate appropriate screening, communication and clinical skills necessary for the prevention, identification, and management of these conditions including non-drug and dietary interventions;
• Explain the relationship between the pharmacology of drugs used to manage diseases in this subject and the pathophysiology of those diseases.

Subject Assessment

• Written > Test/Quiz 1 - (15%) - Group
• Oral > Presentation 1 - (10%) - Group
• Evidence of Immunisation training completion - (%) - Individual
• Written > Case report 1 - (25%) - Individual
• Performance/Practice/Product > Objective structured clinical examination (OSCE) - (50%) - Individual.

Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.